---
$id: https://graph.org.ai/products/commodity/51192017
$type: Product
source: UNSPSC
code: "51192017"
title: "Pegloticase"
class: "51192000"
classTitle: "Antigout drugs"
family: "51190000"
familyTitle: "Agents affecting water and electrolytes"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Pegloticase

**UNSPSC Code**: 51192017
**Class**: [Antigout drugs](Antigout drugs.mdx)
**Family**: [Agents affecting water and electrolytes](../Agents affecting water and electrolytes.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an uricase covalently attached to polyethylene glycol and immobilized enzyme with the chemical formula C1549H2430N408O448S8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier R581OT55EA, chemically known as des-(1-6)-(7-threonine,46-threonine,291-lysine,301-serine)uricase (ec 1.7.3.3, urate oxidase) but generally known as Pegloticase. European Medicines Agency schedules Pegloticase in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB32159. The term Pegloticase is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 22, No. 3, 2008, List 60.) As of Q4 2014, PEGLOTICASE remains the US FDA Preferred Term for this commodity.

